Recombinant Candida tropicalis Enolase-phosphatase E1 (UTR4)

What is Enolase-phosphatase E1 (UTR4) from Candida tropicalis?

Enolase-phosphatase E1 (UTR4) from Candida tropicalis is a bifunctional enzyme that catalyzes a two-step reaction in metabolic pathways. First, it catalyzes the enolization of 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P) to form the intermediate 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate (HK-MTPenyl-1-P). Subsequently, it dephosphorylates this intermediate to produce the acireductone 1,2-dihydroxy-3-keto-5-methylthiopentene (DHK-MTPene) . This enzyme belongs to the HAD-like hydrolase superfamily, specifically within the MasA/MtnC family, and plays a critical role in fungal metabolism .

How does UTR4 differ from other enolases in Candida species?

While UTR4 (Enolase-phosphatase E1) and canonical enolases (like Eno1) both contain "enolase" in their names, they serve distinct functions and belong to different protein families. Traditional enolases from Candida species, such as those from C. albicans and C. tropicalis, are glycolytic enzymes that catalyze the conversion of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis . In contrast, UTR4 functions in metabolic pathways involving sulfur-containing compounds .

Additionally, canonical enolases in Candida species (particularly C. albicans and C. tropicalis) have been extensively studied for their moonlighting functions, including binding to human proteins like vitronectin, fibronectin, and plasminogen with dissociation constants in the 10^-7–10^-8 M range . These interactions contribute to virulence through mechanisms such as tissue adhesion and extracellular matrix degradation . Current research has not yet fully characterized similar moonlighting functions for UTR4.

What are the optimal expression systems for recombinant production of C. tropicalis UTR4?

Based on research with similar fungal proteins, several expression systems can be considered for the recombinant production of C. tropicalis UTR4:

For successful expression of functional C. tropicalis UTR4, the Kluyveromyces lactis system has proven effective for other Candida proteins, as demonstrated with C. tropicalis Pra1 (CtPra1) . This yeast expression system provides an environment more similar to the native conditions, potentially leading to better folding and functionality of the recombinant protein.

What purification strategies yield the highest purity and activity of recombinant UTR4?

A multi-step purification approach is recommended for obtaining high-purity, enzymatically active UTR4:

• Initial Capture: Immobilized metal affinity chromatography (IMAC) using a His-tag fusion construct or ion exchange chromatography.

• Intermediate Purification: Size exclusion chromatography to separate monomeric UTR4 from aggregates and other proteins.

• Polishing Step: Hydrophobic interaction chromatography for removing trace contaminants.

Quality assessment should include SDS-PAGE analysis (to confirm the expected 27 kDa size), enzymatic activity assays measuring both enolization and dephosphorylation activities, and mass spectrometry confirmation . Purification under native conditions is critical to maintain the bifunctional enzymatic activity.

How can researchers develop reliable enzymatic assays for measuring UTR4 activity?

For comprehensive analysis of UTR4's bifunctional activity, researchers should develop assays that measure both enzymatic functions:

Enolization Activity Assay:

• Monitor the conversion of DK-MTP-1-P to HK-MTPenyl-1-P spectrophotometrically at 280 nm.

• Reaction conditions: 50 mM Tris-HCl (pH 7.5), 5 mM MgCl₂, 1 mM DTT, 0.1-0.5 mM substrate, 28°C.

• Calculate initial reaction rates from the linear portion of progress curves.

Dephosphorylation Activity Assay:

• Quantify inorganic phosphate release using the malachite green assay.

• Reaction conditions: Same buffer system with pre-formed or synthetic HK-MTPenyl-1-P substrate.

• Measure absorbance at 630 nm and compare against phosphate standards.

Researchers should validate these assays by determining kinetic parameters (Km, kcat) and testing with known inhibitors to establish assay specificity. The dual functionality requires careful experimental design to distinguish the sequential reactions.

What role might UTR4 play in C. tropicalis virulence mechanisms?

While direct evidence for UTR4's role in C. tropicalis virulence is limited, insights can be drawn from studies of related proteins:

C. tropicalis has demonstrated immune evasion strategies similar to those of C. albicans. For instance, C. tropicalis pH-related antigen 1 (CtPra1) binds to human complement proteins (C3, C3b) and complement regulatory proteins (factor-H, C4BP), thereby inhibiting complement activation pathways by approximately 20-30% . This suggests that C. tropicalis possesses multiple proteins that interact with host immune components.

Given the moonlighting functions observed in other Candida enolases, UTR4 might potentially:

• Contribute to metabolic adaptability during infection

• Interact with host extracellular matrix components

• Play a role in biofilm formation

Researchers investigating UTR4's role in virulence should consider:

• Gene knockout/knockdown studies to assess changes in virulence

• Protein localization studies under infection-mimicking conditions

• Binding assays with host proteins similar to those conducted for other Candida enzymes

How does the structure-function relationship of UTR4 compare with homologous enzymes from other fungal species?

Structural analysis and comparison between UTR4 and similar enzymes can provide insights into its specific enzymatic mechanism and evolutionary adaptations:

Molecular modeling approaches combined with site-directed mutagenesis of predicted catalytic residues would help elucidate the structural basis for UTR4's bifunctional activity. Researchers should consider developing crystal structures to resolve the precise catalytic mechanism, which would facilitate rational inhibitor design.

What are the best approaches for studying potential moonlighting functions of UTR4?

To investigate whether UTR4 exhibits moonlighting functions similar to other Candida proteins:

• Cell Surface Localization Studies:

  • Immunofluorescence microscopy with anti-UTR4 antibodies

  • Cell fractionation followed by Western blotting

  • Flow cytometry with surface-specific labeling

• Host Protein Binding Assays:

  • Surface plasmon resonance (SPR) to quantify binding kinetics with human proteins (as performed for C. albicans and C. tropicalis enolases with vitronectin, fibronectin, and plasminogen)

  • Co-immunoprecipitation from mixed protein solutions

  • ELISA-based binding assays

• Functional Assays:

  • Adhesion inhibition studies using recombinant UTR4 and anti-UTR4 antibodies

  • Assessment of enzymatic activity in different physiological conditions

These methodologies would help determine if UTR4, like other fungal enolases, possesses additional functions beyond its catalytic role in metabolism. The chemical cross-linking method, as used for mapping interaction sites between candidal enolases and human proteins, could also be applied to identify specific binding motifs in UTR4 .

How can researchers effectively compare expression levels of UTR4 across different C. tropicalis clinical isolates?

For reliable comparison of UTR4 expression across clinical isolates:

• qPCR Analysis:

  • Design primers specific to the UTR4 gene region

  • Normalize expression to multiple reference genes (ACT1, PMA1, RPP2B)

  • Use the 2^-ΔΔCt method for relative quantification

• Protein Quantification:

  • Western blotting with anti-UTR4 antibodies

  • Mass spectrometry-based targeted proteomics (SRM/MRM)

  • ELISA for high-throughput screening

• Experimental Design Considerations:

  • Culture clinical isolates under identical conditions

  • Include reference strain (ATCC MYA-3404) as control

  • Test expression under different growth conditions (pH, temperature, nutrients)

This multi-modal approach would provide comprehensive data on UTR4 expression variability, similar to studies performed with CtPra1 where clinical isolates (oral, blood, and peritoneal fluid) showed higher expression levels compared to reference strains .

How can researchers address solubility challenges when working with recombinant UTR4?

Researchers encountering solubility issues with recombinant UTR4 can implement several strategies:

• Optimization of Expression Conditions:

  • Test multiple induction temperatures (16°C, 25°C, 30°C)

  • Vary inducer concentrations

  • Evaluate different media formulations

• Protein Engineering Approaches:

  • Use solubility-enhancing fusion partners (MBP, SUMO, Thioredoxin)

  • Consider truncation constructs based on domain analysis

  • Introduce solubility-enhancing point mutations

• Purification Modifications:

  • Include stabilizing additives (glycerol, amino acids, osmolytes)

  • Test different buffer systems and pH ranges

  • Implement on-column refolding during purification

For particularly challenging cases, researchers might consider native purification from C. tropicalis, following protocols established for isolating native proteins from Candida species, where both membrane-bound and secretory forms have been successfully purified .

What advanced analytical techniques are most informative for characterizing UTR4-substrate interactions?

To gain mechanistic insights into UTR4's interaction with substrates:

• Structural Analysis:

  • X-ray crystallography of UTR4 with substrate analogs

  • NMR for solution-phase dynamics

  • Cryo-EM for visualizing larger complexes

• Binding and Kinetic Studies:

  • Isothermal titration calorimetry for thermodynamic parameters

  • Microscale thermophoresis for affinity measurements

  • Pre-steady-state kinetics using stopped-flow techniques

• Computational Approaches:

  • Molecular dynamics simulations of enzyme-substrate complexes

  • Quantum mechanics/molecular mechanics for reaction mechanism modeling

  • Virtual screening for potential inhibitors

Integration of these techniques would provide comprehensive understanding of UTR4's catalytic mechanism, similar to the detailed structural characterization performed for interactions between candidal enolases and human proteins .

How might UTR4 be exploited as a target for antifungal drug development?

Given the growing concern of antifungal resistance and the increased incidence of non-albicans Candida infections like C. tropicalis , UTR4 represents a potential novel therapeutic target:

• Target Validation Approaches:

  • Generate UTR4 knockout strains and assess viability/virulence

  • Evaluate essentiality in different infection models

  • Determine conservation across resistant Candida strains

• Inhibitor Development Strategies:

  • Structure-based design targeting the active site

  • Fragment-based screening for allosteric inhibitors

  • Repurposing existing HAD-superfamily inhibitors

• Therapeutic Potential Assessment:

  • Evaluate specificity against human homologs

  • Determine efficacy in in vitro and in vivo infection models

  • Assess synergy with existing antifungals

The emergence of resistance to standard antifungal drugs has been associated with increased mortality rates due to invasive Candida infections, particularly in immunocompromised patients . Novel targets like UTR4 could provide alternative therapeutic approaches for resistant strains.

What are the most promising directions for future research on C. tropicalis UTR4?

Several high-priority research directions would significantly advance understanding of C. tropicalis UTR4:

• Functional Genomics:

  • Comprehensive phenotyping of UTR4 mutants under various stresses

  • Transcriptomic analysis to identify co-regulated genes

  • Genetic interaction mapping to identify synthetic lethal partners

• Host-Pathogen Interactions:

  • Investigation of potential immunomodulatory properties

  • Assessment of UTR4 recognition by host immune receptors

  • Evaluation of UTR4 as a biomarker for C. tropicalis infections

• Translational Applications:

  • Development of UTR4-based diagnostic tools

  • Exploration of UTR4 as a vaccine candidate

  • Design of UTR4-targeting therapeutic antibodies

These research directions would build upon the growing body of knowledge on C. tropicalis virulence factors and potentially lead to novel diagnostic and therapeutic approaches for managing C. tropicalis infections, which are increasingly reported in patients with invasive candidiasis or inflammatory bowel diseases .

How does C. tropicalis UTR4 compare functionally to similar enzymes in pathogenic and non-pathogenic fungi?

Comparing UTR4 across fungal species reveals important evolutionary and functional insights:

Researchers should consider how evolutionary adaptations in UTR4 might contribute to C. tropicalis' specific ecological niche and pathogenic potential. Comparative enzyme kinetics across species would provide valuable insights into functional specialization.

What methodological approaches are most effective for studying UTR4's role in multi-species fungal communities?

To understand UTR4's function in polymicrobial contexts:

• Co-culture Experimental Systems:

  • Develop defined fungal consortia with C. tropicalis and other fungi

  • Establish stable mixed-species biofilm models

  • Create microfluidic systems for spatial organization studies

• Gene Expression Analysis in Mixed Communities:

  • Species-specific RNA-Seq from mixed cultures

  • RT-qPCR with highly specific primers

  • NanoString technology for direct counting of target transcripts

• Functional Studies in Mixed Settings:

  • Gene reporter systems (GFP, luciferase) linked to UTR4

  • Metabolic labeling to track UTR4-dependent pathways

  • Selective inhibition studies in mixed communities

This research approach would be particularly relevant given the polymicrobial nature of many fungal infections, where C. tropicalis may interact with other Candida species or bacteria in forming biofilms and establishing infections.

What controls are essential when designing experiments to study UTR4 enzymatic activity?

Robust experimental design requires comprehensive controls:

• Positive Controls:

  • Purified enzymes with known activity from related organisms

  • Chemically synthesized reaction products for calibration

  • Commercially available phosphatases for dephosphorylation activity comparison

• Negative Controls:

  • Heat-inactivated UTR4

  • Catalytically inactive UTR4 mutants (site-directed mutagenesis of predicted active site residues)

  • Reaction mixtures lacking essential cofactors (e.g., Mg²⁺)

• Validation Approaches:

  • Substrate specificity panels to confirm enzyme selectivity

  • Dose-response curves with known inhibitors

  • pH and temperature profiles to establish optimal conditions

• Statistical Considerations:

  • Minimum of triplicate biological replicates

  • Technical replicates within each biological replicate

  • Appropriate statistical tests for data analysis (ANOVA, t-tests)

These controls ensure that observed enzymatic activities are specifically attributable to UTR4 and not to contaminating proteins or spontaneous chemical reactions.

How can researchers effectively integrate UTR4 studies into broader investigations of C. tropicalis pathogenesis?

To contextualize UTR4 research within the broader understanding of C. tropicalis pathogenesis:

• Multi-omics Integration:

  • Correlate UTR4 expression with global transcriptomic profiles

  • Integrate with metabolomic data to understand pathway impacts

  • Connect to proteomic analyses of virulence factor expression

• Infection Model Incorporation:

  • Study UTR4 expression in established C. tropicalis infection models

  • Compare wild-type and UTR4-modified strains in virulence assays

  • Investigate host responses to UTR4 exposure

• Collaborative Research Approaches:

  • Establish standardized C. tropicalis strain collections

  • Develop shared protocols for consistent data generation

  • Create centralized databases for multi-institution data sharing

This integrated approach would help position UTR4 research within the context of C. tropicalis being increasingly recognized as a significant causative agent of fungal diseases worldwide, accounting for up to 31% of infections in Asia and 15-21% in Latin America .